How are emerging plasma biomarkers related to the diagnostic tests currently used in clinical routines? And does the earlier evidence from highly selective research cohorts translate to the heterogeneous real-world data? Researchers at Karolinska Institutet have sought to answer these questions in a study published in eBioMedicine.